Thermo Fisher Scientific (TMO) earnings
In the quarter ended June 2026, Thermo Fisher Scientific had revenue of $12.0B, up 10.5% on a year earlier, and diluted EPS of 4.68.
On July 23, 2026 it reported EPS of 6.03 against an estimate of 5.71 (beat).
The next report is expected on Wednesday, October 21, 2026 before the market opens, with EPS expected around 6.40.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Wed Oct 21, 2026 | Before open | 6.40 | — |
| Last | Thu Jul 23, 2026 | Before open | 5.71 | 6.03 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Thermo Fisher Scientific's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $12.0B | +10.5% | 4.68 | +9.3% | 17.4% | 2026-07-31 |
| Mar 31, 2026 | $11.0B | +6.2% | 4.43 | +11.3% | 16.9% | 2026-05-01 |
| Dec 31, 2025 | $12.2B | +7.2% | — | — | 18.5% | 2026-02-26 |
| Sep 30, 2025 | $11.1B | +4.9% | 4.27 | +0.5% | 17.5% | 2025-10-31 |
| Jun 30, 2025 | $10.9B | +3.0% | 4.28 | +5.9% | 16.9% | 2025-08-01 |
| Mar 31, 2025 | $10.4B | +0.2% | 3.98 | +15.0% | 16.6% | 2025-05-02 |
| Dec 31, 2024 | $11.4B | +4.7% | — | — | 17.7% | 2025-02-20 |
| Sep 30, 2024 | $10.6B | +0.2% | 4.25 | -3.8% | 17.3% | 2024-11-01 |
| Jun 30, 2024 | $10.5B | -1.4% | 4.04 | +15.1% | 17.3% | 2024-08-02 |
| Mar 31, 2024 | $10.3B | -3.4% | 3.46 | +4.2% | 16.1% | 2024-05-03 |
| Dec 31, 2023 | $10.9B | -4.9% | — | — | 17.0% | 2024-02-22 |
| Sep 30, 2023 | $10.6B | -1.0% | 4.42 | +16.6% | 17.6% | 2023-11-03 |
Questions
When does Thermo Fisher Scientific report earnings?
Thermo Fisher Scientific's next earnings report is expected on October 21, 2026 before the market opens.
How did Thermo Fisher Scientific do last quarter?
In the quarter ended June 2026, Thermo Fisher Scientific had revenue of $12.0B, up 10.5% on a year earlier, and diluted EPS of 4.68.
From Thermo Fisher Scientific's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.